Notice2023-11498
Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 31, 2023
Issuing agencies
Health and Human Services DepartmentAgency for Healthcare Research and Quality
Abstract
The Agency for Healthcare Research and Quality (AHRQ) announces a Special Emphasis Panel (SEP) meeting on "Supporting the Management of Substance Use Disorders in Primary Care and other Ambulatory Settings (R18)". This SEP meeting will be closed to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 104 (Wednesday, May 31, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 104 (Wednesday, May 31, 2023)]
[Notices]
[Pages 34857-34858]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-11498]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ)
announces a Special Emphasis Panel (SEP) meeting on ``Supporting the
Management of Substance Use Disorders in Primary Care and other
Ambulatory Settings (R18)''. This SEP meeting will be closed to the
public.
DATES: July 13, 2023.
ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management
Officer, Office of Extramural Research, Education and Priority
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600
Fishers Lane, Rockville, Maryland 20857, Telephone: (301) 427-1557.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
AHRQ, and agree to be available, to conduct on an as needed basis,
scientific reviews of applications for AHRQ support. Individual members
of the Panel do not attend regularly scheduled meetings and do not
serve for fixed terms or a long period of time. Rather, they are asked
to participate in particular review meetings which require their type
of expertise.
The SEP meeting referenced above will be closed to the public in
accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for
``Supporting the Management of Substance Use Disorders in Primary Care
and other Ambulatory Settings (R18)'' are to be reviewed and discussed
at this meeting. The grant applications and the discussions could
disclose confidential trade secrets or
[[Page 34858]]
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: May 24, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-11498 Filed 5-30-23; 8:45 am]
BILLING CODE 4160-90-P
</pre></body>
</html>Indexed from Federal Register on May 31, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.